Features and outcomes of diffuse large B-cell lymphoma of the thyroid in a large contemporary cohort

Leukemia and Lymphoma

Volumn 55, Issue 2, 2014, Pages 283-287

  Costa, Luciano J ^a   Xavier, Ana C ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Diffuse large B cell lymphoma; Population studies; Radiation; Thyroid

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DEATH; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID GLAND; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; THYROID NEOPLASMS; THYROIDECTOMY; UNITED STATES; YOUNG ADULT;

EID: 84904333300     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.802317     Document Type: Article

References (21)

1. Coiffier B, Lepage E, Briere J., et al CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-242. (Pubitemid 34438862)
2. Habermann TM, Weller EA, Morrison V.A., et al Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006;24: 3121-3127. (Pubitemid 46638950)
3. Pfreundschuh M, Kuhnt E, Trumper L., et al CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol 2011;12:1013-1022.
4. Freeman C, Berg JW, Cutler SJ Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-260.
5. Otter R, Gerrits WB, Vd Sandt MM, et al Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol 1989;25:1203-1210. (Pubitemid 19209616)
6. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-994.
7. Ansell SM, Grant CS, Habermann TM Primary thyroid lymphoma. Semin Oncol 1999;26:316-323. (Pubitemid 29272899)
8. Green LD, Mack L, Pasieka TL Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. J Surg Oncol 2006;94:725-736. (Pubitemid 44902073)
9. Fujita A, Tomita N, Fujita H., et al Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan. Med Oncol 2009;26:49-54.
10. Derringer GA, Thompson LD, Frommelt R.A., et al Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 2000;24:623-639. (Pubitemid 30253500)
11. Watanabe N, Noh JY, Narimatsu H, et al Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease. Br J Haematol 2011;153:236-243.
12. Pedersen RK, Pedersen NT Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology 1996;28:25-32. (Pubitemid 26040138)
13. Alzouebi M, Goepel JR, Horsman J.M., et al Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol 2012;40:2075-2080.
14. Rodrigo JA, Hicks LK, Cheung M.C., et al HIV-associated Burkitt lymphoma: good efficacy and tolerance of intensive chemotherapy including CODOX-M/IVAC with or without rituximab in the HAART era. Adv Hematol 2012;2012:735392.
15. Graff-Baker A., Roman SA, Thomas D.C., et al Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Surgery 2009;146:1105-1115.
16. Marcus R, Imrie K, Solal-Celigny P, et al Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. J Clin Oncol 2008;26:4579-4586.
17. Hitchcock S, Ng AK, Fisher D.C., et al Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2002;52:1058-1066. (Pubitemid 34219027)
18. Onal C, Li YX, Miller R.C., et al Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study. Ann Oncol 2011;22:156-164.
19. Thieblemont C, Mayer A, Dumontet C., et al Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002;87:105-111. (Pubitemid 34084678)
20. Mian M, Gaidano G, Conconi A., et al High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study. Leuk Lymphoma 2011;52:823-832.
21. Niitsu N, Okamoto M, Nakamura N., et al Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma. Ann Oncol 2007;18:1203-1208. (Pubitemid 47244367)